• Join
  • Login
  • Contact

Search abstracts / presentations

Information needs for pharmacists, patient advocates and patients to support adherence

  • In: G7 - HIV/AIDS: With improved access to medications, now what? Models to assure adherence and positive outcomes and associated information needs on Tuesday, 6 September 2005, 14:00-17:00
  • At: Cairo (Egypt) (2005)
  • Type: Presentation
  • By: SMITH, Gary (Univeristy of Maryland, Pharmacy Practice and Science, Baltimore, United States of America)
  • Abstract:

    Adherence in the context of patients with HIV/AIDS means the ability of patients to adhere to a regimen of highly active antiretroviral therapy (HAART) in order to achieve and maintain a non-detectable viral load and a CD4+ cell count above 200. Adherence is the most important factor in assuring successful outcomes with HAART. Studies have shown


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses